Joan M Robbins

Title: Joan M Robbins: Innovator in Retroviral Vector Technology

Introduction

Joan M Robbins is a prominent inventor based in San Diego, California, known for her significant contributions to the field of retroviral vector technology. With a total of four patents to her name, Robbins has made strides in developing innovative methods for treating various cancers and proliferative disorders.

Latest Patents

Robbins' latest patents include a retroviral vector having immune-stimulating activity. This patent provides vectors for treating cancers, along with methods for producing such vectors and their applications. Another notable patent involves compositions comprising gamma retrovirus vectors, which relate to replication-competent viral vectors for treating cell proliferative disorders. This disclosure further explores the use of these vectors for delivering and expressing heterologous nucleic acids in both normal and diseased tissues, along with methods and compositions that facilitate such delivery and expression in vivo and in vitro.

Career Highlights

Throughout her career, Robbins has worked with notable companies such as Tocagen Inc. and Immusol, Incorporated. Her work has focused on advancing therapeutic techniques that leverage retroviral vectors for medical applications.

Collaborations

Robbins has collaborated with esteemed colleagues, including Harry E Gruber and Douglas J Jolly, contributing to the advancement of her research and innovations in the field.

Conclusion

Joan M Robbins stands out as a key figure in the development of retroviral vector technology, with her patents paving the way for new treatment methodologies. Her work continues to impact the medical field positively, showcasing the importance of innovation in addressing complex health challenges.